These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6011982)

  • 1. [Cyclonamine (141-E) and capillar fragility in diabetics].
    Cañadell JM
    Rev Clin Esp; 1966 Dec; 103(5):377-80. PubMed ID: 6011982
    [No Abstract]   [Full Text] [Related]  

  • 2. [Decrease of vascular fragility in diabetic retinopathy through calciumdobesilate (author's transl)].
    Freyler H; Sehorst W
    Klin Monbl Augenheilkd; 1974 Feb; 164(2):246-51. PubMed ID: 4842139
    [No Abstract]   [Full Text] [Related]  

  • 3. Calcium dobesilate as a treatment for capillary fragility in diabetic retinopathy.
    Benarroch IS; de Salama Benarroch AR; Nano H; Perez H; Bisceglia H
    Ophthalmologica; 1974; 168(5):370-5. PubMed ID: 4832044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cyclonamine in vascular fragility].
    Linquette M; Hubschman B
    Lille Med; 1968 Apr; 13(4):Suppl:506-10. PubMed ID: 5683299
    [No Abstract]   [Full Text] [Related]  

  • 5. [The hemostatic Dicynon].
    Jaros Z
    Cas Lek Cesk; 1969 Jun; 108(24):739. PubMed ID: 5783181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the action of a vascular protector on diabetic vascular fragility].
    Nove-Josserand G; Chirat P; Bussy L; Bonnamour C; Peaud PY; Ortonne JP; Gaillarde B; Plauchu M
    Lyon Med; 1971 Dec; 226(19):791-4. PubMed ID: 5159275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of the action of an angioprotector on the vascular fragility of diabetic patients].
    Plauchu M; Amourdedieu J; Rollet J; Jandot V; Kressmann J; Reynaud R
    J Med Lyon; 1971 Apr; 52(206):507-9. PubMed ID: 5135646
    [No Abstract]   [Full Text] [Related]  

  • 8. [Capillary resistance and diabetic retinopathy. Effect of Etamsylate (cyclonamine or Dicynone)].
    Sévin R; Cuendet JF
    Ophthalmologica; 1968; 155(3):186-93. PubMed ID: 5652194
    [No Abstract]   [Full Text] [Related]  

  • 9. What is new about the treatment of diabetic retinopathy by calcium dobesilae (Doxium).
    Cuendet JF; Sevin R
    Bull Ophthalmol Soc Egypt; 1976; 69(73):469-74. PubMed ID: 1031108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of diabetic retinopathy and recurrent hemorrhages into the vitreous with calcium dobesilate].
    Favre M
    Ophthalmologica; 1970; 161(4):389-93. PubMed ID: 5483904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of diabetic retinopathy].
    Schertenleib FE
    Ther Umsch; 1972 Mar; 29(3):204-6. PubMed ID: 5012909
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new capillary protector].
    Rass Int Clin Ter; 1969 Nov; 49(21):1393-4. PubMed ID: 5405175
    [No Abstract]   [Full Text] [Related]  

  • 13. [The action of calcium dobesilate in diabetic retinopathy].
    Sevin R; Cuendet JF
    Bull Mem Soc Fr Ophtalmol; 1969; 82():170-80. PubMed ID: 5402400
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contribution of angiosterrometry to the diagnosis of vascular fragility. Its value in control of the therapeutic effectiveness of an angio-protective agent].
    Plauchu M; Bourlier ; Meunier ; Savoye ; Molinie ; Reynaud R
    Lyon Med; 1967 Jul; 218(31):189-96. PubMed ID: 5611644
    [No Abstract]   [Full Text] [Related]  

  • 15. [Capillary fragility in diabetics and its modification by calcium dobesilate].
    Zabel-Langhennig R; Kulle M
    Z Gesamte Inn Med; 1983 Dec; 38(23):633-6. PubMed ID: 6670338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the treatment of vascular fragility appearing during prolonged anticoagulation].
    Cloetens W; Colin W; Michel J
    Angeiologie; 1967; 19(5):53-66. PubMed ID: 5621974
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of calcium dobesilate on capillary fragility in diabetics].
    Beretta P; Sartori F
    Arch Sci Med (Torino); 1977; 134(3):329-36. PubMed ID: 603392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prosthetic "piezotraumatism" and capillary fragility. The therapeutic advantages of etamsylate].
    Laudenbach P; Ragot C; Cosif G
    Actual Odontostomatol (Paris); 1969 Jun; 23(86):249-66. PubMed ID: 4891319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Utilization of a new synthetic hemostatic, dihydroxy-1,4 benzene sulfonate-3 diethylammonium (dicynone) in ophthalmologic practice with diabetics].
    Le Hunsec J; Pierre G
    Bull Soc Ophtalmol Fr; 1967 Jan; 67(1):192-200. PubMed ID: 5611485
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ethamsylate and capillary fragility in diabetics].
    Daubresse JC
    Rev Med Liege; 1971 Aug; 26(15):511-2. PubMed ID: 5562163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.